We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genetically Engineered Abolition of p62 in Fat Tissue Causes Obesity in Mice

By LabMedica International staff writers
Posted on 17 Jan 2013
A recent study linked the scaffold protein p62 (sequestosome 1; SQSTM1), an emerging key molecular link among the metabolic, immune, and proliferative processes of the cell, to the metabolic imbalance that leads to obesity.

Investigators at the Sanford-Burnham Medical Research Institute (La Jolla, CA, USA) had previously worked with a line of obese mice that had been genetically engineered to lack the gene for p62. More...
In the current study, the system was modified so that it was possible to generate lines of mice with p62 lacking only in specific organs or sites in the body.

Results published in the January 2, 2013, issue of the Journal of Clinical Investigation showed that adipocyte specific, but not CNS-, liver-, muscle-, or myeloid-specific p62-deficient mice were obese. The obese mice lacking p62 in their fat tissues weighed more than control animals, expended less energy, had diabetes, and displayed a hyperinflammatory response.

The results further showed that p62 regulated energy metabolism via control of mitochondrial function in brown adipose tissue (BAT). Accordingly, adipocyte-specific p62 deficiency led to impaired mitochondrial function, causing BAT to become unresponsive to beta-adrenergic stimuli. Abolition of p62 led to decreased activation of signaling molecules that controlled mitochondrial function.

“Without p62 you are making lots of fat but not burning energy, and the body thinks it needs to store energy,” said contributing author Dr. Jorge Moscat, a professor in the tumor microenvironment program at the Sanford-Burnham Medical Research Institute. “It is a double whammy.”

Related Links:

Sanford-Burnham Medical Research Institute



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
HPV Test
Allplex HPV28 Detection
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Characterization of EV separated by distinct methods (Photo courtesy of Yuanyuan Liu, Yanbin Guo et al. Engineering, doi.org/10.1016/j.eng.2025.12.009)

Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis

Childhood epilepsy remains a major neurological disorder with unmet needs for accurate, non-invasive biomarkers, as conventional tests such as electroencephalography and neuroimaging can have limited sensitivity... Read more

Molecular Diagnostics

view channel
Image: NeoCircle Study Synopsis (George, A.M., Chen, Y., Gladchuk, S. et al. EMBO Molecular Medicine (2026). DOI: 10.1038/s44321-026-00447-z)

Ultrasensitive MRD Blood Test Detects Early Breast Cancer Recurrence

SAGA Diagnostics (Morrisville, NC, USA), a company specializing in tumor-informed, blood-based cancer detection and precision medicine, announced the publication of a new study evaluating its Pathlight... Read more

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.